blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3105222

EP3105222 - AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.02.2019
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  09.03.2018
FormerGrant of patent is intended
Status updated on  17.10.2017
FormerRequest for examination was made
Status updated on  18.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Respivert Limited
50-100 Holmers Farm Way
High Wycombe, Buckinghamshire HP12 4EG / GB
[2017/32]
Former [2016/51]For all designated states
Respivert Limited
50-100 Holmers Farm Way
High Wycombe, Buckinghamshire HP12 4EG / GB
For all designated states
Topivert Pharma Limited
265 Strand
London WC2R 1BH / GB
Inventor(s)01 / LONGSHAW, Alistair, Ian
Sygnature Discovery Ltd
Biocity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
02 / FORDYCE, Euan, Alexander, Fraser
Sygnature Discovery Ltd
Biocity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
03 / ONIONS, Stuart, Thomas
Sygnature Discovery Ltd
Biocity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
04 / KING-UNDERWOOD, John
Moorend Cottage
School Lane
Pendock Worcestershire GL19 3PW / GB
05 / VENABLE, Jennifer, Diane
609 Glencrest Place
Solana Beach, California 92075 / US
 [2016/51]
Representative(s)Teuten, Andrew John
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2016/51]Teuten, Andrew John
Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ / GB
Application number, filing date15705797.713.02.2015
[2016/51]
WO2015EP53151
Priority number, dateUS201461940282P14.02.2014         Original published format: US 201461940282 P
US201461941064P18.02.2014         Original published format: US 201461941064 P
[2016/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015121444
Date:20.08.2015
Language:EN
[2015/33]
Type: A1 Application with search report 
No.:EP3105222
Date:21.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 20.08.2015 takes the place of the publication of the European patent application.
[2016/51]
Type: B1 Patent specification 
No.:EP3105222
Date:11.04.2018
Language:EN
[2018/15]
Search report(s)International search report - published on:EP20.08.2015
ClassificationIPC:C07D401/14, A61K31/497, A61P29/00, A61P37/00
[2016/51]
CPC:
C07D401/14 (EP,EA,KR,US); A61K9/0075 (EA,US); A61K31/215 (EA,KR);
A61K31/4427 (EP,EA,US); A61K31/497 (EP,EA,KR,US); A61K31/498 (EP,EA,US);
A61K31/5377 (EP,EA,US); A61K31/541 (EP,EA,US); A61K31/551 (EP,EA,US);
A61K45/06 (EA,KR); A61K47/26 (EA,US); A61P1/00 (EP,EA);
A61P1/04 (EP,EA); A61P11/00 (EP,EA); A61P11/02 (EP,EA);
A61P11/06 (EP,EA); A61P11/08 (EP,EA); A61P19/02 (EP,EA);
A61P27/02 (EP,EA); A61P27/04 (EP,EA); A61P27/06 (EP,EA);
A61P27/12 (EP,EA); A61P27/14 (EP,EA); A61P29/00 (EP,EA);
A61P3/10 (EP,EA); A61P31/00 (EP,EA); A61P31/12 (EP,EA);
A61P35/00 (EP,EA); A61P37/00 (EP,EA); A61P37/02 (EP,EA);
A61P37/06 (EP,EA); A61P37/08 (EP,EA); A61P43/00 (EP,EA);
A61P9/00 (EP,EA); C07D401/12 (EP,EA,US); C07D403/14 (EA,KR);
C07D409/14 (EP,EA,KR,US); C07D413/14 (EP,EA,US); C07D487/04 (EP,EA,US);
A61K2300/00 (EA,KR); C07B2200/13 (EA,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/51]
Extension statesBA12.09.2016
ME12.09.2016
TitleGerman:AROMATISCHE HETEROCYCLISCHE VERBINDUNGEN ALS ENTZÜNDUNGSHEMMENDE VERBINDUNGEN[2016/51]
English:AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS[2016/51]
French:COMPOSÉS HÉTÉROCYCLIQUES AROMATIQUES UTILISÉS EN TANT QUE COMPOSÉS ANTI-INFLAMMATOIRES[2016/51]
Entry into regional phase12.09.2016National basic fee paid 
12.09.2016Designation fee(s) paid 
12.09.2016Examination fee paid 
Examination procedure12.09.2016Examination requested  [2016/51]
12.09.2016Date on which the examining division has become responsible
30.03.2017Amendment by applicant (claims and/or description)
18.10.2017Communication of intention to grant the patent
27.02.2018Fee for grant paid
27.02.2018Fee for publishing/printing paid
27.02.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18161869.5  / EP3357919
Opposition(s)14.01.2019No opposition filed within time limit [2019/12]
Fees paidRenewal fee
10.02.2017Renewal fee patent year 03
14.02.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.02.2015
AL11.04.2018
CY11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MC11.04.2018
MK11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
IS11.08.2018
[2022/31]
Former [2021/32]HU13.02.2015
AL11.04.2018
CY11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MC11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
IS11.08.2018
Former [2021/31]AL11.04.2018
CY11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MC11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
IS11.08.2018
Former [2021/26]AL11.04.2018
CY11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MC11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
Former [2019/45]AL11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MC11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
Former [2019/26]AL11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
RO11.04.2018
RS11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
Former [2019/11]AL11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
RO11.04.2018
RS11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
Former [2019/10]AL11.04.2018
CZ11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
RO11.04.2018
RS11.04.2018
SK11.04.2018
BG11.07.2018
Former [2019/09]AL11.04.2018
EE11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
RS11.04.2018
BG11.07.2018
Former [2018/51]AL11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
RS11.04.2018
BG11.07.2018
Former [2018/50]AL11.04.2018
HR11.04.2018
LT11.04.2018
BG11.07.2018
Former [2018/46]AL11.04.2018
LT11.04.2018
Cited inInternational search[AD]WO0043384  (BOEHRINGER INGELHEIM PHARMA [US]) [AD] 1-18 * claims 1,16 *;
 [AD]WO2010112936  (RESPIVERT LTD [GB], et al) [AD] 1-16* claims 1,5 *;
 [A]WO2011124923  (RESPIVERT LTD [GB], et al) [A] 1-18 * claims 1,35 *;
 [A]WO2013050757  (RESPIVERT LTD [GB]) [A] 1-18 * claims 1, 12 *
by applicantWO0043384
 WO2010067131
 WO2010112936
 WO2011070369
 WO2011158039
    - O'KEEFE, S.J. ET AL., J. BIOL. CHEM., (2007), vol. 282, no. 48, pages 34663 - 71
    - FITZSIMMONS, B.L. ET AL., NEUROREPORT, (2010), vol. 21, no. 4, pages 313 - 7
    - PETTUS, L.H.; WURZ, R.P., CURR. TOP. MED. CHEM., (2008), vol. 8, no. 16, pages 1452 - 67
    - GENOVESE ET AL., J. RHEUMATOL., (2011), vol. 38, pages 846 - 54
    - PAMAPIMOD, COHEN ET AL., ARTHRITIS RHEUM., (2009), vol. 60, pages 335 - 344
    - SCHIEVEN ET AL., ARTHRITIS RHEUM., (2010), vol. 62, no. 10, page 1513
    - LOSMAPIMOD, WATZ ET AL., LANCET RESP. MED., (2014), vol. 2, pages 63 - 72
    - SCHREIBER, S. ET AL., CLIN. GASTRO. HEPATOLOGY, (2006), vol. 4, pages 325 - 334
    - SHMUELI, O. ET AL., COMPTES RENDUS BIOLOGIES, (2003), vol. 326, no. 10-11, pages 1067 - 1072
    - SMITH, S. J., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404
    - HALE, K. K., J. IMMUNOL., (1999), vol. 162, no. 7, pages 4246 - 52
    - WANG, X. S. ET AL., J. BIOL. CHEM., (1997), vol. 272, no. 38, pages 23668 - 23674
    - COURT, N. W. ET AL., J. MOL. CELL. CARDIOL., (2002), vol. 34, no. 4, pages 413 - 26
    - MERTENS, S. ET AL., FEBS LETT., (1996), vol. 383, no. 3, pages 273 - 6
    - KUMA, Y., J. BIOL. CHEM., (2005), vol. 280, pages 19472 - 19479
    - CHUNG, F., CHEST, (2011), vol. 139, no. 6, pages 1470 - 1479
    - SMITH ET AL., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404
    - RISCO ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2012), vol. 109, pages 11200 - 11205
    - CRIADO, G. ET AL., ARTHRITIS RHEUM., (2014), vol. 66, no. 5, pages 1208 - 17
    - SMITH, S.J., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404
    - UNDERWOOD, D.C. ET AL., AM. J. PHYSIOL., (2000), vol. 279, pages L895 - 902
    - NATH, P. ET AL., EUR. J. PHARMACOL., (2006), vol. 544, pages 160 - 167
    - IRUSEN, E. ET AL., J. ALLERGY CLIN. IMMUNOL., (2002), vol. 109, pages 649 - 657
    - LEE, M.R.; DOMINGUEZ, C., CURRENT MED. CHEM., (2005), vol. 12, pages 2979 - 2994
    - MERCADO, N. ET AL., MOL. PHARMACOL., (2011), vol. 80, no. 6, pages 1128 - 1135
    - MERCADO, N. ET AL., PLOS ONE, (2012), vol. 7, no. 7, pages E41582,1 - 9
    - PAPI ET AL., J. ALLERGY CLIN. IMMUNOL., (2013), vol. 132, pages 1075 - 1085
    - ARMSTRONG ET AL., JPET, (2011), vol. 338, pages 732 - 740
    - PAPADOPOULOS, N.G. ET AL., PAEDIATR. RESPIR. REV., (2004), vol. 5, no. 3, pages 255 - 260
    - GRUNBERG, K. ET AL., AM. J. RESPIR. CRIT. CARE MED., (2001), vol. 164, no. 10, pages 1816 - 1822
    - WAT, D. ET AL., J. CYST. FIBROS., (2008), vol. 7, pages 320 - 328
    - LIU, M. ET AL., TRANSPL. INFECT. DIS., (2009), vol. 11, no. 4, pages 304 - 312
    - WANG ET AL., J. IMMUNOL., (2009), vol. 183, pages 6989 - 6997
    - MAHMUTOVIC-PERSSON ET AL., ALLERGY, (2014), vol. 69, no. 3, pages 348 - 358
    - WANG, Q. ET AL., PLOS PATHOG., vol. 7, no. 5, page E1002070
    - LAU ET AL., J. IMMUNOL., (2008), vol. 180, pages 870 - 880
    - BENTLEY, J.K. ET AL., J. VIROL., (2007), vol. 81, pages 1186 - 1194
    - INOUE, D. ET AL., RESPIR. PHYSIOL. NEUROBIOL., (2006), vol. 154, no. 3, pages 484 - 499
    - SHILO, Y., NAT. REV. CANCER, (2003), vol. 3, pages 155 - 168
    - OLAHARSKY, A.J. ET AL., PLOS COMPUT. BIOL., (2009), vol. 5, no. 7, page E1000446
    - TIGHE, A. ET AL., BMC CELL BIOLOGY, (2007), vol. 8, page 34
    - SURRY, D.S.; BUCHWALD, S.L., "Biaryl Phosphane Ligands in Palladium-Catalyzed Amination", ANGEW. CHEM. INT. ED., (2008), vol. 47, pages 6338 - 6361
    - SWAMY, K. C.; KUMAR, N. N.; BALARAMAN, E.; KUMAR, K. V., "Mitsunobu and Related Reactions: Advances and Applications", CHEMICAL REVIEWS, (2009), vol. 109, no. 6, doi:doi:10.1021/cr800278z, pages 2551 - 2651, XP055023394

DOI:   http://dx.doi.org/10.1021/cr800278z
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.